Uncategorized pages
From OncoWiki
Jump to navigationJump to search
Showing below up to 328 results in range #1 to #328.
- 5-FU + Cisplatin
- 5-FU + Cisplatin + Docetaxel
- 5-FU + Cisplatin + RT
- 5-FU + Cisplatin + RT + Surgery
- 5-FU + Cisplatin + Vinblastine + RT + Surgery
- 5-FU + LV
- 5-FU + LV + Bevacizumab
- 5-FU + LV + Irinotecan
- 5-FU + LV + Mitomycin + Dipyridamole
- 5-FU + LV + RT
- 5-FU + RT
- 5-FU MitomycinC Radiation Therapy EORTC Regimen
- 5-FU MitomycinC Radiation Therapy Wayne State Regimen
- A-C-T
- ABDIC
- ABVD
- AC
- AD
- ADE
- ADOC
- AI
- AIDA-PETHEMA Group
- APL4 - ALLG
- ASHAP
- ATRA plus As203
- Acute Lymphoblastic Leukemia, Adult
- Acute Lymphoblastic Leukemia, Pediatric
- Acute Myeloid Leukemia,Adult
- Adrenocortical Carcinoma
- Adriamycin + Cisplatin
- Adriamycin + Cisplatin + Paclitaxel
- Alemtuzumab + Fludarabine
- Amrubicin
- Anal Carcinoma
- Arsenic Trioxide for APML, new cases
- Arsenic Trioxide for relapsed APML
- BEAC
- BEAM
- BEP
- BFM- 95 (German Protocol)
- BFM B-Cell
- BeGeV
- Bendamustine
- Bendamustine + Rituximab
- Bevacizumab
- Bevacizumab + Erlotinib
- Bevacizumab + IFN
- BiRD
- Bicalutamide
- Bile Duct Cancer Extrahepatic
- Bladder Cancer
- Bonn protocol
- Brain Tumors Adult
- Breast Cancer
- Brentuximab vedotin
- CAF
- CALGB 8811
- CALGB 9111
- CALGB 9710
- CB
- CBI
- CEOP
- CEP
- CFAR
- CHOEP-14
- CHOP
- CHOP-14
- CIM
- CLAG
- CLAG-M
- CMF
- CMV
- CNOP
- CODOX-M/IVAC
- COPP
- CVD
- CVD + IL-2 + IFN
- CVP
- Cancer treatment information
- CapIri
- Capecitabine + RT
- Carboplatin
- Carboplatin + Docetaxel
- Carboplatin + Etoposide
- Carboplatin + Gemcitabine
- Carboplatin + Irinotecan
- Carboplatin + Paclitaxel
- Carboplatin + Paclitaxel + Bevacizumab
- Carboplatin + Paclitaxel + Etoposide
- Carboplatin + Pemetrexed
- Carboplatin + Vinorelbine
- Carcinoid Tumors, Gastrointestinal
- Cervical Cancer
- Cetuximab
- Cetuximab + Irinotecan
- ChlVPP
- Chlorambucil + Prednisone
- Chronic Lymphocytic Leukemia
- Chronic Myelogenous Leukemia
- Cisplatin
- Cisplatin + 5-FU
- Cisplatin + 5-FU + RT
- Cisplatin + Capecitabine
- Cisplatin + Docetaxel
- Cisplatin + Epirubicin
- Cisplatin + Epirubicin + 5-FU
- Cisplatin + Etoposide
- Cisplatin + Etoposide + Bleomycin
- Cisplatin + Etoposide + RT
- Cisplatin + Etoposide + RT → Docetaxel
- Cisplatin + Etoposide or Vinorelbine or Vinblastine or Vindesine
- Cisplatin + Gemcitabine
- Cisplatin + Gemcitabine + Bevacizumab
- Cisplatin + Irinotecan
- Cisplatin + Irinotecan + Bevacizumab
- Cisplatin + Paclitaxel
- Cisplatin + Pemetrexed
- Cisplatin + RT
- Cisplatin + Topotecan
- Cisplatin + Vinorelbine
- Clofarabine, cyclophosphamide and etoposide
- Colon Cancer
- Current events
- Cyclophosphamide Bortezomib Dexamethasone
- Cytarabine Idarubicin Vorinostat consolidation
- Cytarabine Idarubicin Vorinostat induction
- Cytotoxic Regimens
- DAT
- DHAP
- DHAX
- DT-PACE
- DVD
- Dacarbazine
- Dacarbazine + Cisplatin + Carmustine
- Dactinomycin
- Dasatinib
- DaunoXome
- Dexa-BEAM
- Dexamethasone
- Dexamethosone
- Docetaxel + Estramustine
- Docetaxel + Prednisone
- Doxorubicin
- Doxorubicin + Bleomycin + Vinblastine
- EAPLG
- EBVMm
- ECF
- ECF + surgery + ECF
- EP
- EPIC
- EPOCH
- EPOCH-DA
- ESHAP
- EVA
- EVAP
- Endometrial Cancer
- Erlotinib
- Escalated BEACOPP
- Esophageal Cancer
- Etoposide
- Etoposide + Cisplatin
- Ewing’s sarcoma and primitive neuroectodermal tumor of bone
- FC
- FCM
- FCR
- FLAG
- FLAG-Ida
- FLOFOXIRI
- FLOX
- FN
- FND
- FOLFIRINOX
- FOLFIRI + Bevacizumab
- FOLFIRI + Cetuximab
- FOLFOX
- FOLFOX4
- FOLFOX4 + Bevacizumab
- FOLFOX4 + Cetuximab
- FOLFOX6
- FOLFOX6 + Bevacizumab
- FP + Surgery +/- FP
- FUFOX + Cetuximab
- Flu Bu ATG - Slavin
- Flu Bu ATG for Haplo
- Fludarabine + Prednisone
- Fludarabine + Rituximab
- Flutamide
- Fotemustine
- GEM-P
- GEM-Vinorelbine-Pred
- GVD
- Gastric Cancer
- Gefitinib
- Gemcitabine + 5-FU + RT
- Gemcitabine + Capecitabine
- Gemcitabine + Cisplatin
- Gemcitabine + Cisplatin + Paclitaxel
- Gemcitabine + Docetaxel
- Gemcitabine + Erlotinib
- Gemcitabine + Oxaliplatin
- Gemcitabine + Paclitaxel
- Gemcitabine + Vinorelbine
- Gemtuzumab Ozogamicin
- Goserelin
- Goserelin + Flutamide + RT
- Guidelines for contributors
- Guidelines on using this site
- HAM
- Hairy Cell Leukemia
- Hematological Malignancies
- Hepatocellular Cancer Adult, Primary
- High dose Methotrexate
- HyperCVAD
- HyperCVADHDMTX-AraC
- ICE
- ICE-aml
- IFL + Bevacizumab
- IL-2
- IMVP-16
- IVE
- Ifosfamide
- Ifosfamide + Paclitaxel
- Kaposi's Sarcoma
- Ketoconazole
- Kidney Renal Cell Cancer
- LALA
- LV5FU-P
- LV + 5-FU + Irinotecan + Bevacizumab
- Lenalidomide + Rituximab
- Linker Regimen
- Lung Cancer Non Small Cell
- Lung Cancer Small Cell
- Luprolide
- Lymphoma Hodgkin's, Adult
- Lymphoma Non-Hodgkin's, Adult
- M-BACOD
- MACOP-B
- MAID
- MCP
- MIME
- MINE/ESHAP
- MOPP
- MOPPABV Hybrid
- MP
- MPT
- MRC UKALL XII/ECOG E2993
- MVAC
- Main Page
- Malignant Mesothelioma
- Megestrol acetate
- Melanoma
- MiCMA
- Mini-BEAM
- Mitoxantrone + Prednisone
- Multiple Myeloma And Plasma Cell Dyscrasias
- Myelodysplastic Syndromes
- Nasopharyngeal Cancer
- Nilotinib
- Non-Hematological Malignancies
- Oblimersen + Dacarbazine
- Octreotide
- Ovarian Epithelial Cancer
- Oxaliplatin + Capecitabine
- PAC
- PAD
- PCR
- PCV
- Paclitaxel + Carboplatin + Gemcitabine
- Paclitaxel + Gemcitabine
- Paclitaxel IV + Cisplatin IP + Paclitaxel IP
- Pancreatic Cancer
- Panitumumab
- Pegylated liposomal doxorubicin
- Pemetrexed
- Plerixafor and G-CSF
- Postremission High Dose Cytarabine
- Prednisone
- Prostate Cancer
- R-CHOP
- R-CVP
- R-EPOCH
- R-FCM
- R-FCM + maintenance R
- R-GemOx
- R-MCP
- R-MPV
- RC
- RICE
- RTOG study 93-10
- Rev/Dex
- Rituximab, Bendamustine, Bortezomib
- SMILE
- Sandbox
- Sarcoma
- Satraplatin + Prednisone
- Standard3plus7
- Standard BEACOPP
- Stanford V
- Stem Cell Transplantation
- Streptozocin + 5-FU
- Streptozocin + Doxorubicin
- Sunitinib
- TIP
- Temozolomide + IFN
- Temozolomide + IL-2 + IFN + GM-CSF
- Temozolomide + RT
- Temozolomide + Thalidomide
- Temsirolimus
- Test spam
- Testicular Cancer
- Thal/Dex
- Thymoma And Thymic Carcinoma
- Topotecan
- Total Therapy 1
- Total Therapy 2
- TrophoblasticTumors, Gestational
- Unknown Primary, Carcinoma Of
- VAD
- VDT-PACE
- VIP
- VMP
- VMPT
- VNCOP-B
- VeIP
- Vorinostat
- Weekly Carboplatin + Paclitaxel + RT → Carboplatin + Paclitaxel
- XELIRI + Bevacizumab
- XELOX + Bevacizumab